Subvisible (2–100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis-Reference-Cited by-同舟云学术

Subvisible (2–100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis

Published:2015-11 Issue:6 Volume:43 Page:457-473
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Corvari Vincent,Narhi Linda O.,Spitznagel Thomas M.,Afonina Nataliya,Cao Shawn,Cash Patricia,Cecchini Irene^ORCID,DeFelippis Michael R.,Garidel Patrick,Herre Andrea,Koulov Atanas V.,Lubiniecki Tony,Mahler Hanns-Christian,Mangiagalli Paolo,Nesta Douglas,Perez-Ramirez Bernardo,Polozova Alla,Rossi Mara,Schmidt Roland,Simler Robert,Singh Satish,Weiskopf Andrew,Wuchner Klaus

Publisher

Elsevier BV

Subject

Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Reference47 articles.

1. Particulate matter in injections;US Pharmacopeia,2015

2. Subvisible particulate matter in therapeutic protein injections;US Pharmacopeia,2015

3. Subvisible (2 μm to 100 μm particle analysis during biotherapeutic drug product development: part 1, considerations and strategy;Narhi;J Pharm Sci,2015

4. Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality;Carpenter;J Pharm Sci,2009

5. Chemical modifications in therapeutic protein aggregates generated under different stress conditions;Luo;J Biol Chem,2011

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Destructive Analysis of Subvisible Particles with Mie-Scattering-Based Light Sheet Technology: System Development;Journal of Pharmaceutical Sciences;2024-09

2. Visible light triggers the formation of reactive oxygen species in monoclonal antibody formulations;International Journal of Pharmaceutics;2024-08

3. Challenges at Submicron Particle Characterisation: A Case Study Using Nanoparticle Tracking Analysis (NTA);Journal of Pharmaceutical Innovation;2024-05-15

4. Evaluating Clinical Safety and Analytical Impact of Subvisible Silicone Oil Particles in Biopharmaceutical Products;Journal of Pharmaceutical Sciences;2024-05

5. Correlating Surface Activity with Interface-Induced Aggregation in a High-Concentration mAb Solution;Molecular Pharmaceutics;2024-02-22